T‐cell recognition of oncogene products: A new strategy for immunotherapy

This publication has 38 references indexed in Scilit:

• Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors
  International Journal of Cancer, 1991
• Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185 ^{erb B2}
  Science, 1990
• Expression of the p185 encoded by her2 oncogene in normal and transformed human tissues
  International Journal of Cancer, 1990
• HER-2/neu oncogene protein and prognosis in breast cancer.
  Journal of Clinical Oncology, 1989
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells.
  Proceedings of the National Academy of Sciences, 1988
• p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
  Molecular and Cellular Biology, 1986
• AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO
  The Lancet, 1986
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985
• The Action of Oncogenes in the Cytoplasm and Nucleus
  Science, 1985